The global healthcare industry continues to prioritize disease prevention as governments, healthcare organizations, and pharmaceutical companies strengthen immunization programs worldwide. Vaccination remains one of the most effective public health interventions, reducing disease burden and improving population health outcomes. The Infectious Vaccines Market Share is witnessing significant...

According to a new report from Intel Market Research, the global Herpes Simplex Virus (HSV) Vaccines market was valued at USD 865 million in 2024 and is projected to reach USD 1,360 million by 2034, growing at a robust CAGR of 6.8% during the forecast period (2025–2034). This growth is driven by the increasing global prevalence of HSV infections, rising awareness about sexually...